Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,380	6,276	1,692	1,334	15,306	8,922
Short-Term Investments	-	472.52	1,494	-	-	-
Cash & Short-Term Investments	5,380	6,748	3,187	1,334	15,306	8,922
Cash Growth	51.96%	111.78%	138.79%	-91.28%	71.54%	114.37%
Accounts Receivable	2,203	2,452	2,803	724.02	205.04	93.8
Other Receivables	13.27	2.82	5.42	5.98	4.15	87.22
Receivables	2,216	2,455	2,808	1,330	209.19	181.02
Inventory	1,478	921.32	1,746	1,982	602.35	341.57
Prepaid Expenses	15.56	6.04	8.07	57.1	7.76	285.1
Other Current Assets	34.64	14.03	17.24	52.83	33.04	256.87
Total Current Assets	9,123	10,144	7,767	4,756	16,158	9,987
Property, Plant & Equipment	9,288	8,687	9,765	10,948	7,997	8,048
Long-Term Investments	-	-	-	-0	-0	0
Other Intangible Assets	16.57	21.76	71.88	80.62	58.36	72.7
Long-Term Deferred Charges	-	-	-	636.91	552.08	488.95
Other Long-Term Assets	0.2	0.2	100.28	1,503	52.32	98.03
Total Assets	18,428	18,853	17,704	17,924	24,817	18,695
Accounts Payable	124.97	260.14	239.75	139.18	47.85	19.95
Accrued Expenses	551.12	445.89	521.74	485.06	337.31	321.58
Short-Term Debt	-	-	5,309	4,583	7,401	-
Current Portion of Long-Term Debt	-	-	-	-	-	5,107
Current Portion of Leases	-	92.62	288.27	1,089	7.5	31.38
Other Current Liabilities	205.31	287.53	4,854	1,651	6,185	1,863
Total Current Liabilities	881.4	1,086	11,213	7,947	13,979	7,343
Long-Term Leases	-	-	-	288.27	-	7.04
Other Long-Term Liabilities	0	-	43.52	63.44	41.17	63
Total Liabilities	1,045	1,192	11,484	8,359	14,022	7,413
Common Stock	4,529	4,529	3,742	3,420	3,171	3,021
Additional Paid-In Capital	42,313	42,313	35,585	32,955	31,407	29,911
Retained Earnings	-28,370	-28,092	-32,419	-25,900	-22,872	-20,746
Comprehensive Income & Other	-1,089	-1,089	-688.68	-910.12	-910.12	-904.91
Total Common Equity	17,383	17,661	6,220	9,565	10,796	11,282
Shareholders' Equity	17,383	17,661	6,220	9,565	10,796	11,282
Total Liabilities & Equity	18,428	18,853	17,704	17,924	24,817	18,695
Total Debt	-	92.62	5,597	5,960	7,409	5,146
Net Cash (Debt)	5,380	6,656	-2,410	-4,625	7,897	3,777
Net Cash Growth	80.48%	-	-	-	109.09%	160.63%
Net Cash Per Share	596.43	773.80	-330.86	-702.78	1273.53	774.52
Filing Date Shares Outstanding	8.75	9.06	7.48	6.84	6.34	6.04
Total Common Shares Outstanding	8.75	9.06	7.48	6.84	6.34	6.04
Working Capital	8,242	9,058	-3,446	-3,191	2,179	2,644
Book Value Per Share	1986.80	1949.65	831.11	1398.45	1702.42	1867.27
Tangible Book Value	17,366	17,640	6,148	9,485	10,737	11,209
Tangible Book Value Per Share	1984.91	1947.25	821.51	1386.67	1693.21	1855.23
Land	-	3,041	3,041	3,041	3,041	3,041
Buildings	-	3,568	3,568	3,568	3,568	3,568
Machinery	-	3,194	3,008	2,206	1,565	1,265
Construction In Progress	-	78	268	545.59	-	221.91

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.